Stephen N. Keith

Native Chicagoan, Dr. Stephen Keith began his vast highly influential career in 1980 as a resident in Pediatrics at the University of California Center for Health and Community. From 1980 to 1982, Dr. Keith was a Robert Wood Johnson Foundation Clinical Scholar at the University of California, Los Angeles (UCLA). From 1982 to 1987, Dr. Keith served on the faculty of the Charles Drew Medical School and the University of California, Los Angeles (UCLA) School of Medicine’s Department of Pediatrics. In 1987, Dr. Keith served as the Health Policy Advisor to the U.S. Senate Committee on Labor and Human Resources, now U.S. Senate Committee on Health, Education, Labor, and Pensions under Senator Edward M. Kennedy.

In 1990, at Merck & Co., Inc., Dr. Keith was promoted to a number of positions including Senior Director of Health Care Delivery Policy in Corporate Public Affairs, Senior Customer Manager in the U.S. Human Health Division, and Senior Director of Health Strategies in the Merck-Medco Managed Care Division. In 1995, Dr. Keith served as Vice President of Marketing and Sales at North American Vaccine, Inc. In 2000, Dr. Keith served as President and Chief Operating Officer at Antex Biologics Inc. In 2002, Dr. Keith served as a general Partner at Emerging Technology Partners, a life sciences venture capital firm. In 2003, Dr. Keith served as Managing Director at Glocap Advisors, an investment bank and as a Senior Consultant with the Biologics Consulting Group. In 2006, Dr. Keith served as President and Chief Operating Officer at Panacea Pharmaceuticals, Inc. In 2009, Dr. Keith served as Chief Executive Officer of the American College of Clinical Pharmacology. In 2012, Dr. Keith served as Site Director for WellStreet Urgent Care where he remained before coming to Evanston Technology Partners.

Bachelors from Amherst College, Medical Degree from the University of Illinois, and Masters of Science in Public Health, Dr. Keith utilizes his education, demonstrated work experience, and community mindedness as he serves on the Board of Directors at Cytomedix, Inc., a life science company marketing wound care products, The David Winston A. Winston Health Policy Fellowship, National Medical Fellowship, and Community Health Charities.